BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ICVS - ECPv6.15.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ICVS
X-ORIGINAL-URL:https://icvs.uminho.pt
X-WR-CALDESC:Events for ICVS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20251021T110000
DTEND;TZID=UTC:20251021T120000
DTSTAMP:20260409T205749
CREATED:20250930T101817Z
LAST-MODIFIED:20250930T101817Z
UID:14101-1761044400-1761048000@icvs.uminho.pt
SUMMARY:ICVS Advanced Seminar “The neuromuscular junction as a therapeutic target and source of biomarkers in ALS”
DESCRIPTION:October 21st at 11 am\, don’t miss Richard Robitaille‘s “The neuromuscular junction as a therapeutic target and source of biomarkers in ALS” at the A0.02 auditorium in UMinho’s School of Medicine. \nRichard Robitaille’s research interests include the study of the role of glial modulation in synaptic plasticity in the hippocampus\, interactions of glial cells during the synapse during the formation and the aging of synapse\, the role of those interactions during aging of the synapse and contribution of glial cells in the malfunctioning of neuromuscular junctions in Amyotropic lateral sclerosis (ALS).
URL:https://icvs.uminho.pt/event/icvs-advanced-seminar-the-neuromuscular-junction-as-a-therapeutic-target-and-source-of-biomarkers-in-als/
ATTACH;FMTTYPE=image/png:https://icvs.uminho.pt/wp-content/uploads/2025/09/icvs_advanced_seminar_richard_robitaille.png
END:VEVENT
END:VCALENDAR